Astellas Pharma Inc 2025 SR
The report highlights Astellas Pharma's environmental, health, and safety initiatives for fiscal 2024. Key achievements include a 46% reduction in Scope 1 and 2 greenhouse gas emissions compared to the 2015 base year, aligning with its SBTi-approved 1.5°C target. The company also improved water resource productivity by 86% and waste generation per unit of revenue by 45% relative to 2016. Astellas reaffirmed its commitment to achieving Net Zero by 2050 and conducted detailed physical risk analyses under various climate scenarios. Sustainability indicators were also integrated into executive remuneration to drive progress on environmental goals.
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2025
Type: SR
Pages: 33
Back to company
Astellas Pharma Inc
Ehs Report
The report highlights Astellas Pharma's environmental, health, and safety initiatives for fiscal 2024. Key achievements include a 46% reduction in Scope 1 and 2 greenhouse gas emissions compared to the 2015 base year, aligning with its SBTi-approved 1.5°C target. The company also improved water resource productivity by 86% and waste generation per unit of revenue by 45% relative to 2016. Astellas reaffirmed its commitment to achieving Net Zero by 2050 and conducted detailed physical risk analyses under various climate scenarios. Sustainability indicators were also integrated into executive remuneration to drive progress on environmental goals.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2024 - Mar 31, 2025
Fiscal Year
2024
Published
Jul 1, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Workplace Fatalities
Net Zero Target
Employees